Jeffrey A. Oplinger

1.9k citations

15 papers · 1.6k indexed · 1 hit paper · h-index 13

Physiology top 2%
Molecular Biology
Organic Chemistry top 5%
Biochemistry top 1%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Edward P. Garvey Eric S. Furfine Richard G. Knowles B.J.R. Whittle Ferenc László Leo A. Paquette Matthew L. Fowler Paula Sherman
Topics: Nitric Oxide and Endothelin Effects (5 papers)Chemical synthesis and alkaloids (4 papers)Carbohydrate Chemistry and Synthesis (2 papers)
Cited by: Biochemistry Physiology Biophysics
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States Austria United Kingdom

In The Last Decade

Jeffrey A. Oplinger

15 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo

1997 727 citations Edward P. Garvey, Jeffrey A. Oplinger et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Jeffrey A. Oplinger

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Oplinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Oplinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Oplinger more than expected).

Fields of papers citing papers by Jeffrey A. Oplinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Oplinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Oplinger. The network helps show where Jeffrey A. Oplinger may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Oplinger

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Oplinger. A scholar is included among the top collaborators of Jeffrey A. Oplinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Oplinger. Jeffrey A. Oplinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Discovery of Tertiary Sulfonamides as Potent Liver X Receptor Antagonists 2010 ·Journal of Medicinal Chemistry ·William J. Zuercher,Richard G. Buckholz,Nino Campobasso,Jon L. Collins,Cristin M. Galardi,Robert T. Gampe,(unknown),(unknown),John T. Moore,Jeffrey A. Oplinger,Paul R. Reid,Paul K. Spearing,Thomas B. Stanley,Eugene L. Stewart,Timothy M. Willson	81
2	Evaluation of the therapeutic potential of PPARα agonists for X-linked adrenoleukodystrophy 2003 ·Molecular Genetics and Metabolism ·(unknown),Isabelle Weinhofer,Angela Netik,Sonja Forss‐Petter,Peter J. Brown,Jeffrey A. Oplinger,Maurice Bugaut,Johannes Berger	22
3	N-Phenylamidines as Selective Inhibitors of Human Neuronal Nitric Oxide Synthase: Structure−Activity Studies and Demonstration of in Vivo Activity 1998 ·Journal of Medicinal Chemistry ·Jon L. Collins,Barry G. Shearer,Jeffrey A. Oplinger,Shuliang Lee,Edward P. Garvey,Mark Salter,(unknown),Thimysta C. Burnette,Eric S. Furfine	73
4	1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivobreakdown → 1997 ·Journal of Biological Chemistry ·Edward P. Garvey,Jeffrey A. Oplinger,Eric S. Furfine,(unknown),Ferenc László,B.J.R. Whittle,Richard G. Knowles	727
5	S-2-Naphthylmethyl thioacetimidate hydrobromide: A new odorless reagent for the mild synthesis of substituted acetamidines 1997 ·Tetrahedron Letters ·Barry G. Shearer,Jeffrey A. Oplinger,Shuliang Lee	33
6	Substituted N-Phenylisothioureas: Potent Inhibitors of Human Nitric Oxide Synthase with Neuronal Isoform Selectivity 1997 ·Journal of Medicinal Chemistry ·Barry G. Shearer,Shuliang Lee,Jeffrey A. Oplinger,Lloyd Frick,Edward P. Garvey,Eric S. Furfine	52
7	Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. 1994 ·Journal of Biological Chemistry ·Edward P. Garvey,Jeffrey A. Oplinger,Gerald J. Tanoury,Paula Sherman,Matthew L. Fowler,Susan N. Marshall,(unknown),(unknown),Eric S. Furfine	280
8	Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. 1994 ·Journal of Biological Chemistry ·Eric S. Furfine,(unknown),(unknown),Richard G. Knowles,Mark Salter,(unknown),Colm Duffy,Robert L. Hazelwood,Jeffrey A. Oplinger,Edward P. Garvey	195
9	Limitations in the application of anionic oxy-cope sigmatropy to elaboration of the forskolin nucleus 1989 ·Tetrahedron ·Leo A. Paquette,Jeffrey A. Oplinger	45
10	Synthesis of a structurally modified glycal. (-)-(2R,4S)-2-Methyl-2-vinyl-4-(benzyloxy)-3,4-dihydro-2H-pyran 1988 ·The Journal of Organic Chemistry ·Leo A. Paquette,Jeffrey A. Oplinger	33
11	Synthesis of the forskolin skeleton via anionic oxy-cope rearrangement 1987 ·Tetrahedron Letters ·Jeffrey A. Oplinger,Leo A. Paquette	17
12	Vinylsilane-mediated polyene cyclization. Synthesis of the octahydronaphthalenol portion of dihydrocompactin. 1985 ·Tetrahedron Letters ·Steven D. Burke,Jeffrey O. Saunders,Jeffrey A. Oplinger,C. W. MURTIASHAW	9
13	Total synthesis of (.+-.)-quadrone 1984 ·Journal of the American Chemical Society ·Steven D. Burke,C. W. MURTIASHAW,Jeffrey O. Saunders,Jeffrey A. Oplinger,(unknown)	21
14	A unified approach to prostanoid and corticosteroid synthons 1984 ·Tetrahedron Letters ·Steven D. Burke,David R. Magnin,Jeffrey A. Oplinger,(unknown),Ahmed F. Abdel‐Magid	14
15	Synthetic studies directed at (±)-quadrone. A new end game. 1983 ·Tetrahedron Letters ·Steven D. Burke,C. W. MURTIASHAW,Jeffrey A. Oplinger	12

About Jeffrey A. Oplinger

Jeffrey A. Oplinger is a scholar working on Biochemistry, Organic Chemistry and Biophysics, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (5 papers), Chemical synthesis and alkaloids (4 papers) and Carbohydrate Chemistry and Synthesis (2 papers). The work is most often cited by research in Biochemistry (337 citations), Physiology (906 citations) and Biophysics (149 citations). Jeffrey A. Oplinger has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Edward P. Garvey, Eric S. Furfine, Richard G. Knowles, B.J.R. Whittle, Ferenc László, Leo A. Paquette, Matthew L. Fowler, Paula Sherman, Susan N. Marshall and Gerald J. Tanoury. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact